Cargando…

New Developments and Challenges in Antibody-Based Therapies for the Respiratory Syncytial Virus

Since the discovery of the human respiratory syncytial virus (hRSV), multiple research efforts have been conducted to develop vaccines and treatments capable of reducing the risk of severe disease, hospitalization, long-term sequelae, and death from this pathogen in susceptible populations. In this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diethelm-Varela, Benjamín, Soto, Jorge A, Riedel, Claudia A, Bueno, Susan M, Kalergis, Alexis M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094422/ https://www.ncbi.nlm.nih.gov/pubmed/37063935 http://dx.doi.org/10.2147/IDR.S379660

Ejemplares similares

Antibody development for preventing the human respiratory syncytial virus pathology
por: Soto, Jorge A., et al.
Publicado: (2020)

Bacterial and Viral Coinfections with the Human Respiratory Syncytial Virus
por: Pacheco, Gaspar A., et al.
Publicado: (2021)

Increased Heme Oxygenase 1 Expression upon a Primary Exposure to the Respiratory Syncytial Virus and a Secondary Mycobacterium bovis Infection
por: Canedo-Marroquín, Gisela, et al.
Publicado: (2022)

Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity
por: Canedo-Marroquín, Gisela, et al.
Publicado: (2017)

Potential Neurocognitive Symptoms Due to Respiratory Syncytial Virus Infection
por: Andrade, Catalina A., et al.
Publicado: (2021)

Differential Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Response in Inactivated Virus–Vaccinated, Convalescent, and Breakthrough-Infected Subjects
por: Duarte, Luisa F, et al.
Publicado: (2023)

Modulation of Immune Cells as a Therapy for Cutaneous Lupus Erythematosus
por: Soto, Jorge A., et al.
Publicado: (2022)

Host Components Contributing to Respiratory Syncytial Virus Pathogenesis
por: Carvajal, Jonatan J., et al.
Publicado: (2019)

Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines
por: Topalidou, Xanthippi, et al.
Publicado: (2023)

Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia—Implications for Vaccine Design
por: Rey-Jurado, Emma, et al.
Publicado: (2017)

Contribution of Fcγ Receptor-Mediated Immunity to the Pathogenesis Caused by the Human Respiratory Syncytial Virus
por: Acevedo, Orlando A., et al.
Publicado: (2019)

Cytokines in the Respiratory Airway as Biomarkers of Severity and Prognosis for Respiratory Syncytial Virus Infection: An Update
por: Vázquez, Yaneisi, et al.
Publicado: (2019)

Contribution of Resident Memory CD8(+) T Cells to Protective Immunity against Respiratory Syncytial Virus and Their Impact on Vaccine Design
por: Retamal-Díaz, Angello, et al.
Publicado: (2019)

Functional Impairment of Mononuclear Phagocyte System by the Human Respiratory Syncytial Virus
por: Bohmwald, Karen, et al.
Publicado: (2017)

Characterization of the humoral and cellular immunity induced by a recombinant BCG vaccine for the respiratory syncytial virus in healthy adults
por: Pacheco, Gaspar A., et al.
Publicado: (2023)

Current Animal Models for Understanding the Pathology Caused by the Respiratory Syncytial Virus
por: Altamirano-Lagos, María José, et al.
Publicado: (2019)

Interplay between Lipid Metabolism, Lipid Droplets, and DNA Virus Infections
por: Farías, Mónica A., et al.
Publicado: (2022)

Contribution of Cytokines to Tissue Damage During Human Respiratory Syncytial Virus Infection
por: Bohmwald, Karen, et al.
Publicado: (2019)

Human Metapneumovirus: Mechanisms and Molecular Targets Used by the Virus to Avoid the Immune System
por: Soto, Jorge A., et al.
Publicado: (2018)

Immune-Modulation by the Human Respiratory Syncytial Virus: Focus on Dendritic Cells
por: Tognarelli, Eduardo I., et al.
Publicado: (2019)

Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial
por: Abarca, Katia, et al.
Publicado: (2020)

Respiratory syncytial virus
por: Munoz, Flor M., et al.
Publicado: (2020)

Challenges and Opportunities for Respiratory Syncytial Virus Vaccines
por: Graham, Barney S., et al.
Publicado: (2013)

Severe respiratory disease caused by human respiratory syncytial virus impairs language learning during early infancy
por: Peña, Marcela, et al.
Publicado: (2020)

Challenges and Opportunities in Developing Respiratory Syncytial Virus Therapeutics
por: Simões, Eric A. F., et al.
Publicado: (2015)

Is there a role for HSF1 in viral infections?
por: Reyes, Antonia, et al.
Publicado: (2022)

Respiratory Syncytial Virus
por: Fraire, Armando E., et al.
Publicado: (2013)

A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus
por: Díaz, Fabián E., et al.
Publicado: (2021)

Contribution of autophagy to antiviral immunity
por: Rey-Jurado, Emma, et al.
Publicado: (2015)

Contribution of Two-Dose Vaccination Toward the Reduction of COVID-19 Cases, ICU Hospitalizations and Deaths in Chile Assessed Through Explanatory Generalized Additive Models for Location, Scale, and Shape
por: Reyes, Humberto, et al.
Publicado: (2022)

Respiratory syncytial virus in severe lower respiratory infections in previously healthy young Ethiopian infants
por: Weldetsadik, Abate Yeshidinber, et al.
Publicado: (2021)

Respiratory syncytial virus
por: Ruuskanen, Olli, et al.
Publicado: (1993)

Current State and Challenges in Developing Respiratory Syncytial Virus Vaccines
por: Biagi, Carlotta, et al.
Publicado: (2020)

Modulation of host adaptive immunity by hRSV proteins
por: Espinoza, Janyra A, et al.
Publicado: (2014)

The Role of Dendritic Cells During Infections Caused by Highly Prevalent Viruses
por: Soto, Jorge A., et al.
Publicado: (2020)

A meta-analysis of the effect of antibody therapy for the prevention of severe respiratory syncytial virus infection
por: Morris, Shaun K, et al.
Publicado: (2009)

Rationale for full-season dosing for passive antibody prophylaxis of respiratory syncytial virus
por: Makari, Doris, et al.
Publicado: (2014)

New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV
por: Gálvez, Nicolás M. S., et al.
Publicado: (2017)

The Use of Humanized Monoclonal Antibodies for the Prevention of Respiratory Syncytial Virus Infection
por: Lanari, Marcello, et al.
Publicado: (2013)

An Overview of Respiratory Syncytial Virus
por: Meng, Jia, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ptl2neh6fqeuq1tn5mi4ghjk28